Levels of vaspin and omentin-1 in gingival crevicular fluid as potential markers of inflammation in patients with chronic periodontitis and type 2 diabetes mellitus

Journal of Oral Science

Volumn 58, Issue 3, 2016, Pages 379-389

  Doğan, Şeyma Bozkurt ^a   Dede, Figen Öngöz ^b   Ballı, Umut ^c   Sertoğlu, Erdim ^d  

^a YILDIRIM BEYAZIT UNIVERSITY   (Turkey)

^b ORDU UNIVERSITY   (Turkey)

^c ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

^d GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

Diabetes mellitus; Gingival crevicular fluid; Omentin; Periodontitis; Vaspin

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; ITLN1 PROTEIN, HUMAN; LECTIN; SERINE PROTEINASE INHIBITOR; SERPINA12 PROTEIN, HUMAN;

ADULT; CASE CONTROL STUDY; CHRONIC PERIODONTITIS; GINGIVITIS; HUMAN; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADULT; BIOMARKERS; CASE-CONTROL STUDIES; CHRONIC PERIODONTITIS; CYTOKINES; DIABETES MELLITUS, TYPE 2; GINGIVAL CREVICULAR FLUID; GPI-LINKED PROTEINS; HUMANS; LECTINS; MIDDLE AGED; SERPINS;

EID: 84990831267     PISSN: 13434934     EISSN: 18804926     Source Type: Journal    
DOI: 10.2334/josnusd.15-0731     Document Type: Article

References (47)

1. Listgarten MA (1986) Pathogenesis of periodontitis. J Clin Periodontol 13, 418-430.
2. Salvi GE, Lang NP (2005) Host response modulation in the management of periodontal diseases. J Clin Periodontol 32, Suppl 6, 108-129.
3. Raghavendra NM, Pradeep AR, Kathariya R, Sharma A, Rao NS, Naik SB (2012) Effect of non surgical periodontal therapy on gingival crevicular fluid and serum visfatin concentration in periodontal health and disease. Dis Markers 32, 383-388.
4. Ozdemir SP, Kurtiş B, Tüter G, Bozkurt Ş, Gültekin SE, Sengüven B et al. (2012) Effects of low-dose doxycycline and bisphosphonate clodronate on alveolar bone loss and gingival levels of matrix metalloproteinase-9 and interleukin-1β in rats with diabetes: a histomorphometric and immunohistochemical study. J Periodontol 83, 1172-1182.
5. Duarte PM, Bezerra JP, Miranda TS, Feres M, Chambrone L, Shaddox LM (2014) Local levels of inflammatory mediators in uncontrolled type 2 diabetic subjects with chronic periodontitis. J Clin Periodontol 41, 11-18.
6. Javed F, Al-Askar M, Al-Hezaimi K (2012) Cytokine profile in the gingival crevicular fluid of periodontitis patients with and without type 2 diabetes: a literature review. J Periodontol 83, 156-161.
7. Duarte PM, Miranda TS, Lima JA, Dias Gonçalves TE, Santos VR, Bastos MF et al. (2012) Expression of immuneinflammatory markers in sites of chronic periodontitis in patients with type 2 diabetes. J Periodontol 83, 426-434.
8. Tan BK, Adya R, Randeva HS (2010) Omentin: a novel link between inflammation, diabesity, and cardiovascular disease. Trends Cardiovasc Med 20, 143-148.
9. Pradeep AR, Raghavendra NM, Sharma A, Patel SP, Raju A, Kathariya R et al. (2012) Association of serum and crevicular visfatin levels in periodontal health and disease with type 2 diabetes mellitus. J Periodontol 83, 629-634.
10. Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115, 911-919.
11. Kim SH, Lee SH, Ahn KY, Lee DH, Suh YJ, Cho SG et al. (2014) Effect of lifestyle modification on serum chemerin concentration and its association with insulin sensitivity in overweight and obese adults with type 2 diabetes. Clin Endocrinol (Oxf) 80, 825-833.
12. Luo S, Yang X, Wang D, Ni J, Wu J, Xu Z et al. (2015) Periodontitis contributes to aberrant metabolism in type 2 diabetes mellitus rats by stimulating the expression of adipokines. J Periodontal Res doi: 10.1111/jre.12322.
13. Hida K, Wada J, Eguchi J, Zhang H, Baba M, Seida A et al. (2005) Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci U S A 102, 10610-10615.
14. Li K, Li L, Yang M, Liu H, Liu D, Yang H et al. (2011) Shortterm continuous subcutaneous insulin infusion decreases the plasma vaspin levels in patients with type 2 diabetes mellitus concomitant with improvement in insulin sensitivity. Eur J Endocrinol 164, 905-910.
15. Jian W, Peng W, Xiao S, Li H, Jin J, Dong Y et al. (2014) Role of serum vaspin in progression of type 2 diabetes: a 2-year cohort study. PLoS One 9, e94763.
16. Gulcelik NE, Karakaya J, Gedik A, Usman A, Gurlek A (2009) Serum vaspin levels in type 2 diabetic women in relation to microvascular complications. Eur J Endocrinol 160, 65-70.
17. Teshigawara S, Wada J, Hida K, Nakatsuka A, Eguchi J, Murakami K et al. (2012) Serum vaspin concentrations are closely related to insulin resistance, and rs77060950 at SERPINA12 genetically defines distinct group with higher serum levels in Japanese population. J Clin Endocrinol Metab 97, E1202-1207.
18. Bergmann K, Sypniewska G (2013) Diabetes as a complication of adipose tissue dysfunction. Is there a role for potential new biomarkers? Clin Chem Lab Med 51, 177-185.
19. Pan HY, Guo L, Li Q (2010) Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res Clin Pract 88, 29-33.
20. El-Mesallamy HO, El-Derany MO, Hamdy NM (2011) Serum omentin-1 and chemerin levels are interrelated in patients with Type 2 diabetes mellitus with or without ischaemic heart disease. Diabet Med 28, 1194-1200.
21. Venza I, Visalli M, Cucinotta M, De Grazia G, Teti D, Venza M (2010) Proinflammatory gene expression at chronic periodontitis and peri-implantitis sites in patients with or without type 2 diabetes. J Periodontol 81, 99-108.
22. Gokhale NH, Acharya AB, Patil VS, Trivedi DJ, Setty S, Thakur SL (2014) Resistin levels in gingival crevicular fluid of patients with chronic periodontitis and type 2 diabetes mellitus. J Periodontol 85, 610-617.
23. Armitage GC (1999) Development of a classification system for periodontal diseases and conditions. Ann Periodontol 4, 1-6.
24. İnce G, Gürsoy H, İpçi ŞD, Cakar G, Emekli-Alturfan E, Yılmaz S (2015) Clinical and biochemical evaluation of lozenges containing lactobacillus reuteri as an adjunct to non-surgical periodontal therapy in chronic periodontitis. J Periodontol 86, 746-754.
25. Silness J, Loe H (1964) Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 22, 121-135.
26. Loe H, Silness J (1963) Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 21, 533-551.
27. Ainamo J, Bay I (1975) Problems and proposals for recording gingivitis and plaque. Int Dent J 25, 229-235.
28. Griffiths GS (2003) Formation, collection and significance of gingival crevice fluid. Periodontol 2000 31, 32-42.
29. Ghallab NA, Amr EM, Shaker OG (2015) Expression of leptin and visfatin in gingival tissues of chronic periodontitis with and without type 2 diabetes mellitus: a study using enzymelinked immunosorbent assay and real-time polymerase chain reaction. J Periodontol 86, 882-889.
30. Ogawa H, Damrongrungruang T, Hori S, Nouno K, Minagawa K, Sato M et al. (2014) Effect of periodontal treatment on adipokines in type 2 diabetes. World J Diabetes 5, 924-931.
31. Gangadhar V, Ramesh A, Thomas B (2011) Correlation between leptin and the health of the gingiva: a predictor of medical risk. Indian J Dent Res 22, 537-541.
32. Wu Y, Chen L, Wei B, Luo K, Yan F (2015) Effect of nonsurgical periodontal treatment on visfatin concentrations in serum and gingival crevicular fluid of patients with chronic periodontitis and type 2 diabetes mellitus. J Periodontol 86, 795-800.
33. Youn BS, Klöting N, Kratzsch J, Lee N, Park JW, Song ES et al. (2008) Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 57, 372-377.
34. Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89, 2548-2556.
35. Brosius FC 3rd, Hostetter TH, Kelepouris E, Mitsnefes MM, Moe SM, Moore MA et al. (2006) Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: a science advisory from the American Heart Association Kidney and Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: developed in collaboration with the National Kidney Foundation. Circulation 114, 1083-1087.
36. Pradeep AR, Karvekar S, Nagpal K, Patnaik K (2015) Vaspin: a new adipokine correlating the levels of crevicular fluid and tear fluid in periodontitis and obesity. J Investig Clin Dent doi: 10.1111/jicd.12149.
37. Yang RZ, Lee MJ, Hu H, Pray J, Wu HB, Hansen BC et al. (2006) Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab 290, E1253-1261.
38. Wurm S, Neumeier M, Weigert J, Schäffler A, Buechler C (2007) Plasma levels of leptin, omentin, collagenous repeat-containing sequence of 26-kDa protein (CORS-26) and adiponectin before and after oral glucose uptake in slim adults. Cardiovasc Diabetol 6, 7.
39. Zhang Q, Zhu L, Zheng M, Fan C, Li Y, Zhang D et al. (2014) Changes of serum omentin-1 levels in normal subjects, type 2 diabetes and type 2 diabetes with overweight and obesity in Chinese adults. Ann Endocrinol (Paris) 75, 171-175.
40. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R (2005) Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111, 1448-1454.
41. Schäffler A, Neumeier M, Herfarth H, Fürst A, Schölmerich J, Büchler C (2005) Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta 1732, 96-102.
42. Senolt L, Polanská M, Filková M, Cerezo LA, Pavelka K, Gay S et al. (2010) Vaspin and omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis. Ann Rheum Dis 69, 1410-1411.
43. Taiyeb-Ali TB, Raman RP, Vaithilingam RD (2011) Relationship between periodontal disease and diabetes mellitus: an Asian perspective. Periodontol 2000 56, 258-268.
44. Iacopino AM (2001) Periodontitis and diabetes interrelationships: role of inflammation. Ann Periodontol 6, 125-137.
45. Ribeiro FV, de Mendonça AC, Santos VR, Bastos MF, Figueiredo LC, Duarte PM (2011) Cytokines and bonerelated factors in systemically healthy patients with chronic periodontitis and patients with type 2 diabetes and chronic periodontitis. J Periodontol 82, 1187-1196.
46. Navarro-Sanchez AB, Faria-Almeida R, Bascones-Martinez A (2007) Effect of non-surgical periodontal therapy on clinical and immunological response and glycaemic control in type 2 diabetic patients with moderate periodontitis. J Clin Periodontol 34, 835-843.
47. Dağ A, Firat ET, Arikan S, Kadiroğlu AK, Kaplan A (2009) The effect of periodontal therapy on serum TNF-alpha and HbA1c levels in type 2 diabetic patients. Aust Dent J 54, 17-22.